Table 2. Association of Pharmaceutical Company Opioid Marketing With Prescription Opioid Overdose Deaths Across All US Countiesa.
Characteristic | aRR (95% CI)b | ||
---|---|---|---|
Model A | Model B | Model C | |
Marketing value, $ per 1000 population per year | 1.09 (1.05-1.12) | NA | NA |
No. of payments, per 1000 population per year | NA | 1.18 (1.14-1.21) | NA |
No. of physicians receiving payments, per 1000 population per year | NA | NA | 1.12 (1.08-1.16) |
Age group, % | |||
18-34 y | 1.05 (1.03-1.07) | 1.04 (1.02-1.06) | 1.05 (1.03-1.06) |
35-64 y | 1.10 (1.07-1.12) | 1.09 (1.07-1.12) | 1.09 (1.07-1.12) |
≥65 y | 1.01 (0.99-1.02) | 1.01 (0.99-1.02) | 1.01 (1.00-1.03) |
Male, % | 0.93 (0.91-0.95) | 0.94 (0.92-0.96) | 0.94 (0.92-0.96) |
White, % | 1.01 (1.01-1.02) | 1.01 (1.01-1.02) | 1.01 (1.01-1.02) |
High school or lower education, % | 1.00 (1.00-1.01) | 1.00 (1.00-1.01) | 1.00 (1.00-1.01) |
Unemployment, % | 1.03 (1.01-1.04) | 1.03 (1.02-1.05) | 1.03 (1.01-1.04) |
Poverty, % | 1.03 (1.01-1.04) | 1.03 (1.01-1.04) | 1.03 (1.01-1.04) |
Median household income ($1000) | 1.00 (1.00-1.01) | 1.00 (1.00-1.01) | 1.00 (1.00-1.01) |
Gini indexc | 1.01 (1.00-1.02) | 1.00 (1.00-1.02) | 1.01 (1.00-1.02) |
Metropolitan area | 1.21 (1.11-1.31) | 1.13 (1.04-1.22) | 1.20 (1.10-1.30) |
Abbreviations: aRR, adjusted relative risk; NA, not applicable.
N = 9398 county-years for each analysis.
Model A includes marketing value (in dollars) as the independent variable, model B includes number of payments as the independent variable, and model C includes number of physicians receiving payments as the independent variable. Each model also includes all other covariates listed in the table.